Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07280260 · ClinicalTrials.gov registry record · Phase 4

Clinical Performance of Nobel N1 System

A Phase 4 study of Tooth Loss and Dental Implant, sponsored by Louisiana State University Health Sciences Center in New Orleans.

Recruiting
Registry status
Phase 4
Development phase
50
Enrollment target
1
Study location

NCT07280260 is a Phase 4 study of Tooth Loss and Dental Implant that is actively recruiting participants, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 50 participants, below the 100-participant average among 11 other Tooth Loss trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07280260, a Phase 4 study of Tooth Loss and Dental Implant, is actively recruiting participants, sponsored by Louisiana State University Health Sciences Center in New Orleans.

RECRUITING
Registry status
Phase 4
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate whether N1 dental implants are successful when a final crown is placed on them at 6 weeks from implant placement surgery.

Interventions

  • DEVICE Nobel N1 implant

Study Locations (1)

Louisiana

  • LSU School of Dentistry - New Orleans

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-12-15
Est. Completion 2028-01-30
Phase Phase 4

What the Registry Record Tells You About NCT07280260

The ClinicalTrials.gov registry entry for NCT07280260 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 11 other Tooth Loss trials with a reported enrollment target (50% lower). The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tooth Loss appearing as the primary indexed condition, and to 1 intervention - of which Nobel N1 implant is the first listed.

NCT07280260 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT07280260 about?

NCT07280260 is a clinical study titled "Clinical Performance of Nobel N1 System". The purpose of the study is to evaluate whether N1 dental implants are successful when a final crown is placed on them at 6 weeks from implant placement surgery.

What is the current status of trial NCT07280260?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2025-12-15. Estimated completion is 2028-01-30.

What conditions does trial NCT07280260 study?

This clinical trial studies the following conditions: Tooth Loss, Dental Implant.

What interventions are being tested in trial NCT07280260?

The interventions under investigation include: Nobel N1 implant (DEVICE).

Who is sponsoring clinical trial NCT07280260?

This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07280260 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tooth Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.